GeneDx is trading at $88.30, up +4.12%, with no clear company-specific announcement found for September 2, 2026.
- The latest identified catalyst was August 3 second-quarter results and reaffirmed guidance, not a new overnight event.
- Broader futures were modestly weaker, so the gain is not clearly explained by market direction.
- The catalyst remains unconfirmed; further filings or news could clarify the move.